Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib-Reference-Cited by-同舟云学术

Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib

Published:2019-11-23 Issue:1 Volume:24 Page:465-475
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cellular Molecular Medi

Author:

Atzori Maria Grazia¹,Ceci Claudia¹,Ruffini Federica²,Trapani Mauro¹,Barbaccia Maria Luisa¹,Tentori Lucio¹,D'Atri Stefania²,Lacal Pedro Miguel²,Graziani Grazia¹^ORCID

Affiliation:

1. Department of Systems Medicine University of Rome Tor Vergata Rome Italy

2. Laboratory of Molecular Oncology IDI‐IRCCS Rome Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14755

Reference48 articles.

1. Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors

2. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

3. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders

4. Involvement of Flt‐1 tyrosine kinase (vascular endothelial growth factor receptor‐1) in pathological angiogenesis;Hiratsuka S;Cancer Res,2001

5. Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating cancer stem cell characteristics in CD133+ melanoma cells through HIF1α, KLF4, and SHH silencing;2024-08-30

2. Molecular Susceptibility and Treatment Challenges in Melanoma;Cells;2024-08-20

3. Determinants of resistance and response to melanoma therapy;Nature Cancer;2024-07-17

4. Extracellular vesicles promote migration despite BRAF inhibitor treatment in malignant melanoma cells;Cell Communication and Signaling;2024-05-22

5. Medicinal attributes of thienopyrimidine scaffolds incorporating the aryl urea motif as potential anticancer candidates via VEGFR inhibition;Archiv der Pharmazie;2024-05-13